Legislation to clarify the FDA’s authority over lab-developed diagnostic tests could wind up back in Congress this year during talks to reauthorize key pandemic preparedness programs, a top FDA official said.https://t.co/UdGYywnrUl
— Bloomberg Law (@BLaw) January 14, 2023
Source: Twitter
Discover more from Justice News247
Subscribe to get the latest posts sent to your email.